Перейти к содержимому

REdI 2024 | D2S04-2 - Q&A Discussion Panel

U.S. Food and Drug Administration

0:00 / 0:00

REdI 2024 | D2S04-2 - Q&A Discussion Panel

88 просмотров · 1 год назад
U.S. Food and Drug Administration
200 тыс. подписчиков
88 просмотров · 1 год назад
The last of three Q&A discussion panels for day two of Regulatory Education for Industry (REdI) Annual Conference 2024. **No Timestamps** Speakers: Jessica Bernhardt, MS ESG Program Manager Division of Application Services (DAS) Enterprise Application Branch (EAB) Office of Digital Transformation (ODT) Office of Information Management and Technology (OIMT) | FDA Bin Duan ESG NextGen Lead Architect CTO Precise Software Solutions Inc. Qi Liu, PhD, MStat, FCP Associate Director for Innovation & Partnership Office of Clinical Pharmacology (OCP) Office of Translational Sciences (OTS) Center for drug Evaluation and Research (CDER) | FDA Learn more at: https://www.fda.gov/drugs/news-events... ----------------------- FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research. Upcoming Training - https://www.fda.gov/cdersbia SBIA Listserv - https://public.govdelivery.com/accoun... SBIA 2024 Playlist -    • 2024 CDER Small Business and Industry Assi...   SBIA LinkedIn -   / cder-small-business-and-industry-assistance   SBIA Training Resources - https://www.fda.gov/cdersbialearn Twitter -   / fda_drug_info   Email - CDERSBIA@fda.hhs.gov Phone - (301) 796-6707 I (866) 405-5367